Profile | GDS5420 / 223010_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1172.11 | 82 |
GSM1296119 | B_lesional_pre-dose | 3529.62 | 95 |
GSM1296076 | C_lesional_pre-dose | 2637.6 | 91 |
GSM1296092 | D_lesional_pre-dose | 2066.97 | 89 |
GSM1296103 | E_lesional_pre-dose | 1602.68 | 86 |
GSM1296078 | F_lesional_pre-dose | 2399.38 | 90 |
GSM1296107 | G_lesional_pre-dose | 2985.47 | 93 |
GSM1296109 | H_lesional_pre-dose | 2035.68 | 90 |
GSM1296080 | I_lesional_pre-dose | 515.88 | 68 |
GSM1296090 | J_lesional_pre-dose | 2534.57 | 91 |
GSM1296074 | K_lesional_pre-dose | 2550.43 | 91 |
GSM1296111 | L_lesional_pre-dose | 3003.4 | 94 |
GSM1296099 | M_lesional_pre-dose | 2473.1 | 92 |
GSM1296086 | O_lesional_pre-dose | 2154 | 89 |
GSM1296117 | P_lesional_pre-dose | 3212.85 | 95 |
GSM1296113 | Q_lesional_pre-dose | 2784.78 | 94 |
GSM1296096 | R_lesional_pre-dose | 2436.66 | 91 |
GSM1296105 | S_lesional_pre-dose | 1314.72 | 84 |
GSM1296098 | T_lesional_pre-dose | 1206.12 | 82 |
GSM1296101 | U_lesional_pre-dose | 1573.78 | 86 |
GSM1296121 | V_lesional_pre-dose | 3488.84 | 95 |
GSM1296088 | W_lesional_pre-dose | 1341.56 | 83 |
GSM1296082 | X_lesional_pre-dose | 2810.12 | 92 |
GSM1296115 | Y_lesional_pre-dose | 3289.78 | 95 |
GSM1296084 | Z_lesional_pre-dose | 1412.2 | 84 |
GSM1296072 | B_lesional_day8 | 3070.79 | 94 |
GSM1296069 | L_lesional_day8 | 3194.66 | 95 |
GSM1296071 | P_lesional_day8 | 2601.04 | 93 |
GSM1296070 | Y_lesional_day8 | 2747.68 | 94 |
GSM1296073 | V_lesional_day8 | 3431.25 | 94 |
GSM1296034 | A_lesional_day15 | 568.35 | 69 |
GSM1296041 | G_lesional_day15 | 3176.44 | 94 |
GSM1296035 | R_lesional_day15 | 2211.84 | 90 |
GSM1296038 | U_lesional_day15 | 2395.33 | 91 |
GSM1296047 | B_lesional_day15 | 2869.22 | 94 |
GSM1296039 | E_lesional_day15 | 3588.96 | 94 |
GSM1296042 | H_lesional_day15 | 2652.2 | 93 |
GSM1296043 | L_lesional_day15 | 2543.37 | 93 |
GSM1296037 | M_lesional_day15 | 1787.22 | 88 |
GSM1296046 | P_lesional_day15 | 2825.59 | 94 |
GSM1296044 | Q_lesional_day15 | 2663.17 | 93 |
GSM1296045 | Y_lesional_day15 | 2675.58 | 93 |
GSM1296025 | C_lesional_day15 | 586.4 | 70 |
GSM1296033 | D_lesional_day15 | 1277.36 | 83 |
GSM1296027 | I_lesional_day15 | 967.5 | 78 |
GSM1296032 | J_lesional_day15 | 1191.71 | 82 |
GSM1296024 | K_lesional_day15 | 619.66 | 71 |
GSM1296031 | W_lesional_day15 | 1404.9 | 85 |
GSM1296028 | X_lesional_day15 | 1112.37 | 81 |
GSM1296029 | Z_lesional_day15 | 943.75 | 78 |
GSM1296026 | F_lesional_day15 | 685.37 | 73 |
GSM1296030 | O_lesional_day15 | 937.4 | 78 |
GSM1296040 | S_lesional_day15 | 1256.54 | 83 |
GSM1296036 | T_lesional_day15 | 1148.12 | 81 |
GSM1296048 | V_lesional_day15 | 3274.38 | 94 |
GSM1296059 | A_lesional_day43 | 1626.91 | 86 |
GSM1296066 | G_lesional_day43 | 3039.96 | 94 |
GSM1296060 | R_lesional_day43 | 2581.96 | 92 |
GSM1296063 | U_lesional_day43 | 3191.76 | 94 |
GSM1296064 | E_lesional_day43 | 3450.62 | 94 |
GSM1296067 | H_lesional_day43 | 2078.36 | 91 |
GSM1296062 | M_lesional_day43 | 1180.11 | 82 |
GSM1296068 | Q_lesional_day43 | 2833.65 | 94 |
GSM1296050 | C_lesional_day43 | 1836.85 | 88 |
GSM1296057 | D_lesional_day43 | 2421.08 | 92 |
GSM1296052 | I_lesional_day43 | 916.8 | 77 |
GSM1296054 | J_lesional_day43 | 746.03 | 74 |
GSM1296049 | K_lesional_day43 | 720.33 | 74 |
GSM1296055 | W_lesional_day43 | 2289.44 | 91 |
GSM1296053 | X_lesional_day43 | 629.56 | 71 |
GSM1296058 | Z_lesional_day43 | 1627.53 | 86 |
GSM1296051 | F_lesional_day43 | 2131.41 | 89 |
GSM1296056 | O_lesional_day43 | 2694.75 | 92 |
GSM1296065 | S_lesional_day43 | 2924.8 | 94 |
GSM1296061 | T_lesional_day43 | 988.99 | 79 |
GSM1296095 | A_non-lesional_pre-dose | 2800.74 | 92 |
GSM1296120 | B_non-lesional_pre-dose | 3125.43 | 94 |
GSM1296077 | C_non-lesional_pre-dose | 973.03 | 78 |
GSM1296093 | D_non-lesional_pre-dose | 545.42 | 69 |
GSM1296104 | E_non-lesional_pre-dose | 3163.16 | 93 |
GSM1296079 | F_non-lesional_pre-dose | 954.46 | 78 |
GSM1296108 | G_non-lesional_pre-dose | 2696.25 | 93 |
GSM1296110 | H_non-lesional_pre-dose | 2087.07 | 91 |
GSM1296081 | I_non-lesional_pre-dose | 308.38 | 60 |
GSM1296091 | J_non-lesional_pre-dose | 2027.11 | 89 |
GSM1296075 | K_non-lesional_pre-dose | 2077.36 | 89 |
GSM1296112 | L_non-lesional_pre-dose | 2422.44 | 93 |
GSM1296100 | M_non-lesional_pre-dose | 1992.05 | 89 |
GSM1296087 | O_non-lesional_pre-dose | 960.78 | 78 |
GSM1296118 | P_non-lesional_pre-dose | 2732.76 | 94 |
GSM1296114 | Q_non-lesional_pre-dose | 2537.37 | 92 |
GSM1296097 | R_non-lesional_pre-dose | 2776.14 | 93 |
GSM1296106 | S_non-lesional_pre-dose | 2183.17 | 91 |
GSM1296102 | U_non-lesional_pre-dose | 1481.25 | 86 |
GSM1296122 | V_non-lesional_pre-dose | 2785.08 | 93 |
GSM1296089 | W_non-lesional_pre-dose | 1484.26 | 86 |
GSM1296083 | X_non-lesional_pre-dose | 558.32 | 69 |
GSM1296116 | Y_non-lesional_pre-dose | 2781.04 | 94 |
GSM1296085 | Z_non-lesional_pre-dose | 912.05 | 77 |